ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,379.68
0.07%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Relay Therapeutics Inc (RLAY)

  7. Relay Therapeutics Inc (RLAY) News

Relay Therapeutics (RLAY)

Relay Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RLAY
DateTimeSourceHeadlineSymbolCompany
06/06/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
06/06/202412:00GlobeNewswire Inc.Relay Therapeutics Discloses Three New Programs at New Program & Platform EventNASDAQ:RLAYRelay Therapeutics Inc
06/06/202401:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202401:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202401:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
05/06/202421:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLAYRelay Therapeutics Inc
05/06/202421:05GlobeNewswire Inc.Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608NASDAQ:RLAYRelay Therapeutics Inc
04/06/202421:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLAYRelay Therapeutics Inc
03/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
21/05/202421:05GlobeNewswire Inc.Relay Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
13/05/202413:30GlobeNewswire Inc.Relay Therapeutics to Host New Program and Platform Event on June 6, 2024NASDAQ:RLAYRelay Therapeutics Inc
02/05/202421:05GlobeNewswire Inc.Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
25/04/202421:05GlobeNewswire Inc.Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024NASDAQ:RLAYRelay Therapeutics Inc
11/04/202421:05GlobeNewswire Inc.Relay Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
26/02/202421:05GlobeNewswire Inc.Relay Therapeutics to Participate in Three Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
22/02/202421:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RLAYRelay Therapeutics Inc
22/02/202421:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RLAYRelay Therapeutics Inc
22/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
22/02/202421:05GlobeNewswire Inc.Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
15/02/202421:05GlobeNewswire Inc.Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024NASDAQ:RLAYRelay Therapeutics Inc
01/02/202421:05GlobeNewswire Inc.Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:RLAYRelay Therapeutics Inc
31/01/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
31/01/202421:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
18/01/202421:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
18/01/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
18/01/202421:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
10/01/202414:22Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RLAYRelay Therapeutics Inc
10/01/202414:14Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RLAYRelay Therapeutics Inc
08/01/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLAY

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
ALTN
Altyngold
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved